For more than 50 years, Besins Healthcare has discovered, developed and delivered healthcare solutions to help women successfully manage the often unexpected issues related to the transition through menopause. Our products are prescribed by physicians in more than 100 countries worldwide.
Globally we are a major player in Menopause Hormone Therapy (MHT), having developed a transdermal estradiol gel, and a micronised natural progesterone in an oily formulation (Prometrium®), bioavailable by oral route of administration. In 2016 we made Prometrium, micronised progesterone, available in Australia for menopause hormone therapy in women; along with Utrogestan®, micronised progesterone, for luteal phase support in ART.
In 2014, Besins Healthcare Australia resumed responsibility for Testogel®, a therapy developed and introduced by our company for hypogonadism.
Besins remains committed to discovering additional innovations in menopause, gynaecology, fertility and obstetrics. In 2019 we are proud to be able to expand our MHT range of products for Australian women transitioning through menopause.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Our history, our mission and our values tell the story of who we are as a company.
We began as a pharmaceutical distributor, providing products to customers in smaller communities.
Today we are one of the world’s leading generics and specialty pharmaceutical companies, with sales in approximately 145 countries and territories.
Our dedication to providing access to medicine continues to grow after more than 50 years.
Mylan Health Pty Ltd
High Tech Medical
Novo Nordisk Pharmaceuticals Pty Ltd